Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus

<p>Abstract</p> <p>Background</p> <p>The consumption of foods containing probiotic and prebiotic ingredients is growing consistently every year, and in view of the limited number of studies investigating their effect in the elderly.</p> <p>Objective</p>...

Full description

Bibliographic Details
Main Authors: Moroti Camila, Souza Magri Loyanne, de Rezende Costa Marcela, Cavallini Daniela CU, Sivieri Katia
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://www.lipidworld.com/content/11/1/29
_version_ 1811320202750590976
author Moroti Camila
Souza Magri Loyanne
de Rezende Costa Marcela
Cavallini Daniela CU
Sivieri Katia
author_facet Moroti Camila
Souza Magri Loyanne
de Rezende Costa Marcela
Cavallini Daniela CU
Sivieri Katia
author_sort Moroti Camila
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The consumption of foods containing probiotic and prebiotic ingredients is growing consistently every year, and in view of the limited number of studies investigating their effect in the elderly.</p> <p>Objective</p> <p>The objective of this study was to evaluate the effect of the consumption of a symbiotic shake containing <it>Lactobacillus acidophilus, Bifidobacterium bifidum </it>and fructooligosaccharides on glycemia and cholesterol levels in elderly people.</p> <p>Methods</p> <p>A randomized, double-blind, placebo-controlled study was conducted on twenty volunteers (ten for placebo group and ten for symbiotic group), aged 50 to 60 years. The criteria for inclusion in the study were: total cholesterol > 200 mg/dL; triglycerides > 200 mg/dL and glycemia > 110 mg/dL. Over a total test period of 30 days, 10 individuals (the symbiotic group) consumed a daily dose of 200 mL of a symbiotic shake containing 10<sup>8 </sup>UFC/mL <it>Lactobacillus acidophilus</it>, 10<sup>8 </sup>UFC/mL <it>Bifidobacterium bifidum </it>and 2 g oligofructose, while 10 other volunteers (the placebo group) drank daily the same amount of a shake that did not contain any symbiotic bacteria. Blood samples were collected 15 days prior to the start of the experiment and at 10-day intervals after the beginning of the shake intake. The standard lipid profile (total cholesterol, triglycerides and HDL cholesterol) and glycemia, or blood sugar levels, were evaluated by an enzyme colorimetric assay.</p> <p>Results</p> <p>The results of the symbiotic group showed a non-significant reduction (<it>P </it>> 0.05) in total cholesterol and triglycerides, a significant increase (<it>P </it>< 0.05) in HDL cholesterol and a significant reduction (<it>P </it>< 0.05) in fasting glycemia. No significant changes were observed in the placebo group.</p> <p>Conclusion</p> <p>The consumption of symbiotic shake resulted in a significant increase in HDL and a significant decrease of glycemia.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov: <a href="http://www.clinicaltrials.gov/ct2/show/NCT00123456">NCT00123456</a></p>
first_indexed 2024-04-13T12:55:56Z
format Article
id doaj.art-87cb7cb3fb0048e596ec4f5db2e57a91
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-04-13T12:55:56Z
publishDate 2012-02-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-87cb7cb3fb0048e596ec4f5db2e57a912022-12-22T02:46:04ZengBMCLipids in Health and Disease1476-511X2012-02-011112910.1186/1476-511X-11-29Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitusMoroti CamilaSouza Magri Loyannede Rezende Costa MarcelaCavallini Daniela CUSivieri Katia<p>Abstract</p> <p>Background</p> <p>The consumption of foods containing probiotic and prebiotic ingredients is growing consistently every year, and in view of the limited number of studies investigating their effect in the elderly.</p> <p>Objective</p> <p>The objective of this study was to evaluate the effect of the consumption of a symbiotic shake containing <it>Lactobacillus acidophilus, Bifidobacterium bifidum </it>and fructooligosaccharides on glycemia and cholesterol levels in elderly people.</p> <p>Methods</p> <p>A randomized, double-blind, placebo-controlled study was conducted on twenty volunteers (ten for placebo group and ten for symbiotic group), aged 50 to 60 years. The criteria for inclusion in the study were: total cholesterol > 200 mg/dL; triglycerides > 200 mg/dL and glycemia > 110 mg/dL. Over a total test period of 30 days, 10 individuals (the symbiotic group) consumed a daily dose of 200 mL of a symbiotic shake containing 10<sup>8 </sup>UFC/mL <it>Lactobacillus acidophilus</it>, 10<sup>8 </sup>UFC/mL <it>Bifidobacterium bifidum </it>and 2 g oligofructose, while 10 other volunteers (the placebo group) drank daily the same amount of a shake that did not contain any symbiotic bacteria. Blood samples were collected 15 days prior to the start of the experiment and at 10-day intervals after the beginning of the shake intake. The standard lipid profile (total cholesterol, triglycerides and HDL cholesterol) and glycemia, or blood sugar levels, were evaluated by an enzyme colorimetric assay.</p> <p>Results</p> <p>The results of the symbiotic group showed a non-significant reduction (<it>P </it>> 0.05) in total cholesterol and triglycerides, a significant increase (<it>P </it>< 0.05) in HDL cholesterol and a significant reduction (<it>P </it>< 0.05) in fasting glycemia. No significant changes were observed in the placebo group.</p> <p>Conclusion</p> <p>The consumption of symbiotic shake resulted in a significant increase in HDL and a significant decrease of glycemia.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov: <a href="http://www.clinicaltrials.gov/ct2/show/NCT00123456">NCT00123456</a></p>http://www.lipidworld.com/content/11/1/29<it>Bifidobacterium bifidum</it>Fructooligosaccharide<it>Lactobacillus acidophilus</it>Symbiotics<it>Shake</it>
spellingShingle Moroti Camila
Souza Magri Loyanne
de Rezende Costa Marcela
Cavallini Daniela CU
Sivieri Katia
Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
Lipids in Health and Disease
<it>Bifidobacterium bifidum</it>
Fructooligosaccharide
<it>Lactobacillus acidophilus</it>
Symbiotics
<it>Shake</it>
title Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_full Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_fullStr Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_full_unstemmed Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_short Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_sort effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
topic <it>Bifidobacterium bifidum</it>
Fructooligosaccharide
<it>Lactobacillus acidophilus</it>
Symbiotics
<it>Shake</it>
url http://www.lipidworld.com/content/11/1/29
work_keys_str_mv AT moroticamila effectoftheconsumptionofanewsymbioticshakeonglycemiaandcholesterollevelsinelderlypeoplewithtype2diabetesmellitus
AT souzamagriloyanne effectoftheconsumptionofanewsymbioticshakeonglycemiaandcholesterollevelsinelderlypeoplewithtype2diabetesmellitus
AT derezendecostamarcela effectoftheconsumptionofanewsymbioticshakeonglycemiaandcholesterollevelsinelderlypeoplewithtype2diabetesmellitus
AT cavallinidanielacu effectoftheconsumptionofanewsymbioticshakeonglycemiaandcholesterollevelsinelderlypeoplewithtype2diabetesmellitus
AT sivierikatia effectoftheconsumptionofanewsymbioticshakeonglycemiaandcholesterollevelsinelderlypeoplewithtype2diabetesmellitus